MedPath

Captopril

Captopril Tablets, USP for oral use Rx only

Approved
Approval ID

2d3779b0-83d9-4b6f-a043-f7768cd7fce6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 20, 2023

Manufacturers
FDA

Solco Healthcare US, LLC

DUNS: 828343017

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Captopril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-364
Application NumberANDA074477
Product Classification
M
Marketing Category
C73584
G
Generic Name
Captopril
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification

INGREDIENTS (5)

CAPTOPRILActive
Quantity: 25 mg in 1 1
Code: 9G64RSX1XD
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

Captopril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-365
Application NumberANDA074477
Product Classification
M
Marketing Category
C73584
G
Generic Name
Captopril
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CAPTOPRILActive
Quantity: 50 mg in 1 1
Code: 9G64RSX1XD
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

Captopril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-363
Application NumberANDA074477
Product Classification
M
Marketing Category
C73584
G
Generic Name
Captopril
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification

INGREDIENTS (5)

STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CAPTOPRILActive
Quantity: 12.5 mg in 1 1
Code: 9G64RSX1XD
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

Captopril

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-366
Application NumberANDA074477
Product Classification
M
Marketing Category
C73584
G
Generic Name
Captopril
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2023
FDA Product Classification

INGREDIENTS (5)

CAPTOPRILActive
Quantity: 100 mg in 1 1
Code: 9G64RSX1XD
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Captopril - FDA Drug Approval Details